Breaking News Instant updates and real-time market news.

KITE

Kite Pharma

$51.80

1.24 (2.45%)

07:12
11/21/16
11/21
07:12
11/21/16
07:12

Kite Pharma initiated with a Buy at H.C. Wainwright

H.C. Wainwright analyst Corey Davis started Kite Pharma with a Buy rating and $78 price target. While the competition for Chimeric Antigen Receptor T-cells is intense, Kite should have a big first-mover advantage with KTE-C19, Davis tells investors in a research note.

  • 03

    Dec

  • 03

    Dec

KITE Kite Pharma
$51.80

1.24 (2.45%)

09/27/16
LEER
09/27/16
NO CHANGE
LEER
Outperform
Kite's ZUMA-1 interim data incrementally positive for Juno, says Leerink
Leerink analyst Michael Schmidt says Kite Pharma's (KITE) top-line interim results from its pivotal ZUMA-1 trial of anti-CD19 CAR-T product KTE-C19 in patients with chemorefractory diffuse large B-cell lymphoma, or DLBCL, are incrementally positive for Juno Therapeutics (JUNO). While Juno is roughly one year behind Kite in DLBCL, the analyst believes its JCAR017 holds the promise to have a compelling safety/efficacy profile in lymphoma and Acute Lymphoblastic Leukemia. He reiterates an Outperform rating on Juno's shares.
10/07/16
GSCO
10/07/16
NO CHANGE
GSCO
Smid-cap Biotech sector upgraded to Attractive from Neutral at Goldman
Goldman analyst Salveen Richter upgraded the Smid-cap biotechnology to Attractive and said he favors and companies with near-term pipeline data or regulatory events where he has conviction.Names he recommends are Buy rated BioMarin (BMRN), bluebird bio (BLUE), GW Pharma (GWPH), Incyte (INCY), Kite (KITE), and Sage (SAGE).
10/10/16
ADAM
10/10/16
NO CHANGE
Target $75
ADAM
Buy
Kite Pharma BLA filing still expected by year end, says Canaccord
Canaccord analyst John Newman noted Kite Pharma released 12 month update on Zuma-1 Phase 1, which showed durable efficacy and is encouraging despite coming from a small patient group. The analyst saw the release as a continuation of positive trends and expects a BLA filing by the end of 2016. Newman reiterated his Buy rating and $75 price target on Kite Pharma shares.
11/10/16
RBCM
11/10/16
NO CHANGE
RBCM
Kite Pharma weakness creates buying opportunity, says RBC Capital
After Kite's stock fell recently, RBC Capital analyst Michael Yee blames the pullback on macro worries about the biotech sector and a number of "short-term questions," about several issues, including upcoming ASH data, new durability data expected next quarter, and questions about the FDA's view of its drug. However, the analyst thinks that the company's comments indicate that its talks with the FDA are going well, and he says he remains upbeat on the company's pipeline. He expects "a lot" of concerns about the company to be mitigated in the next three to six m,months, as he thinks that it will report positive data in the near to medium term.The analyst keeps an $85 price target and an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

ABIL

Ability

$1.40

0.14 (11.11%)

08:09
06/27/17
06/27
08:09
06/27/17
08:09
Hot Stocks
Ability regains Nasdaq listing compliance »

Ability received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCYT

Veracyte

$7.90

0.14 (1.80%)

08:09
06/27/17
06/27
08:09
06/27/17
08:09
Hot Stocks
Veracyte says study published supporting Envisia Genomic Classifier »

Veracyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$53.74

-0.59 (-1.09%)

08:08
06/27/17
06/27
08:08
06/27/17
08:08
Recommendations
PayPal analyst commentary  »

PayPal could free up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

RCII

Rent-A-Center

$11.48

0.28 (2.50%)

08:08
06/27/17
06/27
08:08
06/27/17
08:08
Hot Stocks
Rent-A-Center names Martin Evans chief human resources officer »

Rent-A-Center announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$248.91

2.45 (0.99%)

08:07
06/27/17
06/27
08:07
06/27/17
08:07
Hot Stocks
Allergan launches Refresh Optive Mega-3 artificial tears »

Allergan launched the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSTG

Biostage

$0.34

0.025 (7.94%)

08:07
06/27/17
06/27
08:07
06/27/17
08:07
Syndicate
Biostage raises $3.1M in a private placement »

Biostage announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBVX

MabVax Therapeutics

$1.46

-0.0775 (-5.04%)

08:06
06/27/17
06/27
08:06
06/27/17
08:06
Hot Stocks
MabVax Therapeutics begins dosing in Phase 1 clinical trial evaluating MVT-1075 »

MabVax Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPLD

Upland Software

$22.29

-0.21 (-0.93%)

08:06
06/27/17
06/27
08:06
06/27/17
08:06
Initiation
Upland Software initiated  »

Upland Software initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVIV

InVivo Therapeutics

$2.55

-0.3 (-10.53%)

08:05
06/27/17
06/27
08:05
06/27/17
08:05
Hot Stocks
InVivo Therapeutics announces new patient enrollment in INSPIRE study »

InVivo Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

PHG

Philips

$36.74

-0.12 (-0.33%)

08:04
06/27/17
06/27
08:04
06/27/17
08:04
Hot Stocks
Philips receives FDA 510(k) clearance to market IntelliSpace Portal 9.0 »

Royal Philips announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$90.08

1.35 (1.52%)

08:03
06/27/17
06/27
08:03
06/27/17
08:03
Technical Analysis
Technical View: Darden trades near 52-week high after earnings »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 18

    Jul

  • 19

    Jul

KSS

Kohl's

$37.52

0.49 (1.32%)

, SVU

Supervalu

$3.03

0.09 (3.06%)

08:03
06/27/17
06/27
08:03
06/27/17
08:03
Hot Stocks
Kohl's appoints Bruce Besanko as CFO »

Kohl's (KSS)…

KSS

Kohl's

$37.52

0.49 (1.32%)

SVU

Supervalu

$3.03

0.09 (3.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$65.92

-0.24 (-0.36%)

, SNY

Sanofi

$49.59

0.26 (0.53%)

08:03
06/27/17
06/27
08:03
06/27/17
08:03
Recommendations
Merck, Sanofi, Johnson & Johnson, Bristol-Myers, Pfizer, Roche, Novartis, AstraZeneca, GlaxoSmithKline, Eli Lilly analyst commentary  »

Large cap pharma could…

MRK

Merck

$65.92

-0.24 (-0.36%)

SNY

Sanofi

$49.59

0.26 (0.53%)

JNJ

Johnson & Johnson

$136.34

-0.09 (-0.07%)

BMY

Bristol-Myers

$56.92

0.28 (0.49%)

PFE

Pfizer

$34.04

-0.13 (-0.38%)

RHHBY

Roche

$32.47

-0.29 (-0.89%)

NVS

Novartis

$85.75

-0.59 (-0.68%)

AZN

AstraZeneca

$35.15

0.08 (0.23%)

GSK

GlaxoSmithKline

$44.07

-0.22 (-0.50%)

LLY

Eli Lilly

$84.28

0.39 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 11

    Jul

  • 12

    Jul

  • 13

    Jul

  • 18

    Jul

  • 27

    Jul

  • 30

    Jul

  • 02

    Aug

  • 27

    Aug

  • 22

    Sep

  • 24

    Sep

NFEC

NF Energy

$0.92

0.01 (1.10%)

08:02
06/27/17
06/27
08:02
06/27/17
08:02
Hot Stocks
NF Energy signs $600K valve sales contract »

NF Energy signed a $600K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROV

Trovagene

$1.12

-0.02 (-1.75%)

08:02
06/27/17
06/27
08:02
06/27/17
08:02
Hot Stocks
Trovagene submits IND application to FDA for Phase 1b/2 trial of PCM-075 »

Trovagene announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWKS

Skyworks

$101.32

-3.04 (-2.91%)

08:00
06/27/17
06/27
08:00
06/27/17
08:00
Options
Skyworks put buyer realizes 14% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHAK

Shake Shack

$35.54

-1.46 (-3.95%)

07:59
06/27/17
06/27
07:59
06/27/17
07:59
Recommendations
Shake Shack analyst commentary  »

Shake Shack Q2 comps may…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MON

Monsanto

$117.80

0.78 (0.67%)

, BAYRY

Bayer

$136.70

0.34 (0.25%)

07:56
06/27/17
06/27
07:56
06/27/17
07:56
Downgrade
Monsanto, Bayer rating change  »

Monsanto downgraded to…

MON

Monsanto

$117.80

0.78 (0.67%)

BAYRY

Bayer

$136.70

0.34 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

07:55
06/27/17
06/27
07:55
06/27/17
07:55
General news
U.S. chain store sales climbed 2.9% in the week ended June 24 »

U.S. chain store sales…

RARX

RA Pharmaceuticals

$22.18

-0.83 (-3.61%)

07:55
06/27/17
06/27
07:55
06/27/17
07:55
Conference/Events
RA Pharmaceuticals to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

WDC

Western Digital

$92.66

-0.68 (-0.73%)

07:54
06/27/17
06/27
07:54
06/27/17
07:54
Recommendations
Western Digital analyst commentary  »

Morgan Stanley has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$515.91

-1.42 (-0.27%)

07:53
06/27/17
06/27
07:53
06/27/17
07:53
Recommendations
Regeneron analyst commentary  »

Regeneron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FARM

Farmer Bros.

$30.75

0.7 (2.33%)

07:50
06/27/17
06/27
07:50
06/27/17
07:50
Conference/Events
Farmer Bros. management to meet with B. Riley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

07:50
06/27/17
06/27
07:50
06/27/17
07:50
General news
Treasury Market Outlook: bond yields have jumped higher »

Treasury Market Outlook:…

AMRC

Amerseco

$7.15

0.15 (2.14%)

, SSNI

Silver Spring

$11.51

0.05 (0.44%)

07:49
06/27/17
06/27
07:49
06/27/17
07:49
Hot Stocks
Amerseco selected by Chicago for Smart Street Lighting Project »

Ameresco (AMRC) announced…

AMRC

Amerseco

$7.15

0.15 (2.14%)

SSNI

Silver Spring

$11.51

0.05 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.